The role of this work was not to assess the benefits of anti-TNF therapy, although it is speculated that this treatment may have been, after all, beneficial in different ways and may have accounted for the variability in the study results, including studies comparing RA and PsA. The gene discussed is TNF; the disease is rheumatoid arthritis.